US OptionsDetailed Quotes
BMY240906C47500
- 2.49
- 0.000.00%
15min DelayClose Sep 3 16:00 ET
0.00High0.00Low
2.49Open2.49Pre Close0 Volume128 Open Interest47.50Strike Price0.00Turnover41.30%IV-1.05%PremiumSep 6, 2024Expiry Date3.02Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9696Delta0.0408Gamma16.54Leverage Ratio-0.0233Theta0.0030Rho16.03Eff Leverage0.0028Vega
Bristol-Myers Squibb Stock Discussion
Sign in to post a comment
🚀 Buckle up for upcoming PDUFAs in September! 👇
$Travere Therapeutic (TVTX.US)$ : FILSPARI (Sparsentan)
$Avadel Pharmaceuticals (AVDL.US)$ : LUMRYZ (FT218)
$Iterum Therapeutics (ITRM.US)$ : Sulopenem - AdCom 🗓️
$Sanofi (SNY.US)$ & $Regeneron Pharmaceuticals (REGN.US)$ : Dupixent
$Vanda Pharmaceuticals (VNDA.US)$ : Tradipitant
$Zevra Therapeutics (ZVRA.US)$ : Arimoclomol
$Heron Therapeutics (HRTX.US)$ : ZYNRELEF® Vial Access Needle
$Merck & Co (MRK.US)$ : KEYTRUDA+ chemotherapy
$Bristol-Myers Squibb (BMY.US)$ : KarXT (...
$Travere Therapeutic (TVTX.US)$ : FILSPARI (Sparsentan)
$Avadel Pharmaceuticals (AVDL.US)$ : LUMRYZ (FT218)
$Iterum Therapeutics (ITRM.US)$ : Sulopenem - AdCom 🗓️
$Sanofi (SNY.US)$ & $Regeneron Pharmaceuticals (REGN.US)$ : Dupixent
$Vanda Pharmaceuticals (VNDA.US)$ : Tradipitant
$Zevra Therapeutics (ZVRA.US)$ : Arimoclomol
$Heron Therapeutics (HRTX.US)$ : ZYNRELEF® Vial Access Needle
$Merck & Co (MRK.US)$ : KEYTRUDA+ chemotherapy
$Bristol-Myers Squibb (BMY.US)$ : KarXT (...
7
4
🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...
7
Morning Movers
Gapping up
$Royal Philips (PHG.US)$ experienced a significant boost of 10.6% after the company reported robust second-quarter earnings, attributing much of their success to cost-saving measures, including workforce reductions, and a substantial insurance payout related to liability claims.
$Tesla (TSLA.US)$ 's shares advanced by 1.9% following an endorsement by Morgan Stanley analyst Adam Jonas, naming it the top ...
Gapping up
$Royal Philips (PHG.US)$ experienced a significant boost of 10.6% after the company reported robust second-quarter earnings, attributing much of their success to cost-saving measures, including workforce reductions, and a substantial insurance payout related to liability claims.
$Tesla (TSLA.US)$ 's shares advanced by 1.9% following an endorsement by Morgan Stanley analyst Adam Jonas, naming it the top ...
33
8
$Bristol-Myers Squibb (BMY.US)$ It's about DAYUM time this stock showed some life! Hopefully it won't give it all back!
1
Sold this stock today for a marginal gain to free up some cash to get a better quality stock. When I started to build my portfolio on 9 June, I made a lot of rookie mistakes. while this stock is not one of those, the price was right to let it go for now. I will be circling back to this stock because it is undervalued and has growth potential.
Do you think this is a right move?
Do you think this is a right move?
2
5
$FundStrategyTest$Sell BMY at 49.106, profit ratio +18%
Sell AON at 320.62, profit ratio +13.33%
Sell BLK at 843.83, profit ratio +9.88%
Sell AON at 320.62, profit ratio +13.33%
Sell BLK at 843.83, profit ratio +9.88%
3
1
Morning Movers
Gapping up
$Coinbase (COIN.US)$ 's stock saw a 5.2% increase as it followed the rise in bitcoin prices, with the leading cryptocurrency up approximately 4% after a downturn the previous day.
Semiconductor stocks experienced a rebound, with $NVIDIA (NVDA.US)$ , $Broadcom (AVGO.US)$ , $Qualcomm (QCOM.US)$ , and $Micron Technology (MU.US)$ all posting gains exceeding 2%. This movement came as the sector attempted to r...
Gapping up
$Coinbase (COIN.US)$ 's stock saw a 5.2% increase as it followed the rise in bitcoin prices, with the leading cryptocurrency up approximately 4% after a downturn the previous day.
Semiconductor stocks experienced a rebound, with $NVIDIA (NVDA.US)$ , $Broadcom (AVGO.US)$ , $Qualcomm (QCOM.US)$ , and $Micron Technology (MU.US)$ all posting gains exceeding 2%. This movement came as the sector attempted to r...
38
3
$Verizon (VZ.US)$ $Cadence Design Systems (CDNS.US)$ $NXP Semiconductors (NXPI.US)$ $Coca-Cola (KO.US)$ $GE Aerospace (GE.US)$ $Spotify Technology (SPOT.US)$ $Alphabet-A (GOOGL.US)$ $Tesla (TSLA.US)$ $Visa (V.US)$ $Texas Instruments (TXN.US)$ $Vertiv Holdings (VRT.US)$ $ServiceNow (NOW.US)$ $KLA Corp (KLAC.US)$ $IBM Corp (IBM.US)$ $Chipotle Mexican Grill (CMG.US)$ $Ford Motor (F.US)$ $AbbVie (ABBV.US)$ $American Airlines (AAL.US)$ $British American Tobacco (BTI.US)$ $Bristol-Myers Squibb (BMY.US)$ $3M (MMM.US)$
📊⚡️📊
📊⚡️📊
7
1
Dividend stocks haven't been taking off these days, and that's in part due to high interest rates. When investors can get healthy returns from low-risk, interest-paying assets, the case for buying dividend stocks is naturally less appealing. But the good news for long-term investors is that this means stock prices for some solid dividend stocks are low, and there are some enticing deals available right now.
Bristol Myers Squibb $Bristol-Myers Squibb (BMY.US)$ , Cisco S...
Bristol Myers Squibb $Bristol-Myers Squibb (BMY.US)$ , Cisco S...
+1
78
20
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
No comment yet
RDK79 : Sorry, what’s a pdufa?
Xyno RDK79 : Prescription Drug User Fee Act, means FDA approval or rejection for a drug to go to market. One of the most important events to monitor if you are into pharma companies stock.
RDK79 Xyno : Thank you!
Tonyco : What site is that?